A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly

In conclusion, our findings underscore the potential of QL-007 as an effective agent against HBV replication and introduce it as a novel CpAM for the antiviral treatment of chronic hepatitis B.PMID:37683938 | DOI:10.1016/j.antiviral.2023.105715

Source: Antiviral Research - September 8, 2023 Category: Virology Authors: Jingyuan Xi Zhiqiang Gu Chunyan Sun Zimin Chen Ting Zhang Ran Chen Tianyu Liu Hao Liao Jun Zou Danli Yang Qiang Xu Jie Wang Guochao Wei Zhe Cheng Fengmin Lu Xiangmei Chen Source Type: research